Spark Investment Management LLC - PROTALIX BIOTHERAPEUTICS INC ownership

PROTALIX BIOTHERAPEUTICS INC's ticker is PLX and the CUSIP is 74365A101. A total of 37 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.

Quarter-by-quarter ownership
Spark Investment Management LLC ownership history of PROTALIX BIOTHERAPEUTICS INC
ValueSharesWeighting
Q4 2016$10,000
-70.6%
23,800
-61.0%
0.00%
-66.7%
Q3 2016$34,000
-26.1%
61,100
-16.5%
0.00%
-25.0%
Q2 2016$46,000
-50.0%
73,200
-33.2%
0.00%
-55.6%
Q1 2016$92,000
-60.7%
109,634
-52.2%
0.01%
-70.0%
Q4 2015$234,000
+568.6%
229,600
+658.5%
0.03%
+500.0%
Q3 2015$35,000
+12.9%
30,272
+86.9%
0.01%
+25.0%
Q2 2015$31,000
+10.7%
16,2000.0%0.00%0.0%
Q1 2015$28,000
-81.0%
16,200
-79.9%
0.00%
-84.0%
Q4 2014$147,000
-35.2%
80,400
-14.4%
0.02%
-26.5%
Q3 2014$227,000
+34.3%
93,900
+102.4%
0.03%
+36.0%
Q2 2014$169,00046,4000.02%
Other shareholders
PROTALIX BIOTHERAPEUTICS INC shareholders Q2 2015
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 1,178,440$5,338,0005.83%
GREAT POINT PARTNERS LLC 399,007$1,808,0001.25%
Camber Capital Management LP 1,790,000$8,109,0000.85%
MENORA MIVTACHIM HOLDINGS LTD. 1,041,078$4,716,0000.43%
FEDERATED HERMES, INC. 10,427,472$47,237,0000.18%
SILVERBACK ASSET MANAGEMENT LLC 272,200$1,233,0000.10%
Catalyst Capital Advisors LLC 30,000$136,0000.07%
OBERWEIS ASSET MANAGEMENT INC/ 54,200$246,0000.07%
Baillie Gifford 5,548,351$25,134,0000.06%
Fore Research & Management, LP 200,000$906,0000.06%
View complete list of PROTALIX BIOTHERAPEUTICS INC shareholders